Author:
Iturbe Julián,Leone José Pablo,Zwenger Ariel,Vallejo Carlos,Leone Bernardo
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Chia YH, Ellis MJ, Ma CX (2010) Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool. Br J Cancer 103:759–764
2. Liu SV, Melstrom L, Yao K et al (2010) Neoadjuvant therapy for breast cancer. J Surg Oncol 101:283–291
3. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
4. Colleoni M, Gelber S, Coates AS et al (2001) Influence of endocrine-related factors on response to perioperative chemotherapy for pts with node-negative breast cancer. J Clin Oncol 19:4141–4149
5. Gianni L, Baselga J, Eiermann W et al (2002) First report of the European Cooperative Trial in operable breast cancer (ECTO): effects of primary systemic therapy (PST) on local-regional disease. Proc Am Soc Clin Oncol 21:Abstract 132